Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 82

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 82
---
 a facsimile signature
or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying with the U.S.
federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall be binding
upon the signatory thereto with the same force and effect as if the signature were an original signature.

h. Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

i. The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party. The term “or” shall not be exclusive.

<div align='center'>* * * * * *</div>

| 13 |

IN WITNESS WHEREOF,
the parties have caused this Registration Rights Agreement to be duly executed as of the Execution Date.

| THE COMPANY:                |
| BIODEXA PHARMACEUTICALS PLC |
| By:/s/ Stephen Stamp        |
| Name: Stephen Stamp         |
| Title:   CEO                |
| INVESTOR:                   |
| C/M CAPITAL MASTER FUND, LP |
| By: /s/ Jonathan Juchno     |
| Name: Jonathan Juchno       |
| Title:   General Partner    |

| 14 |

<div align='center'>EXHIBIT A

TO REGISTRATION RIGHTS AGREEMENT

Information About The Investor Furnished To The Company By The Investor

Expressly For Use In Connection With The Registration
Statement</div>

Information With Respect to C/M Capital Master Fund, LP

As of the date of the Purchase Agreement, C/M
Capital Master Fund, LP, did not beneficially own any of our Depositary Shares or Ordinary Shares represented by Depositary Shares. Thomas
Walsh and Jonathan Juchno, the Managing Partners of C/M Capital Master Fund, LP, are deemed to be beneficial owners of all of the Depositary
Shares or Ordinary Shares represented by Depositary Shares owned by C/M Capital Master Fund, LP. Messrs. Walsh and Juchno have shared
voting and